五度妙笔
API商城
数据库Clicklinks | 新药圈你好，我是原创新药创新工场
引言
我知道，你们已经见过我大哥AI-STAL了——那位坐拥十万亿分子库的“藏经阁长老”。也见过我二哥SAI-DA了——那位执加速之剑、策马冲锋的“白衣骑士”。
而今天，三弟我，正式来赴这场三兄弟齐聚的江湖盛会。
我叫Clicklinks，中文名“原创新药创新工场”，是三优生物旗下最年轻、也最具活力的存在。
有人说，大哥负责“源头活水”，二哥负责“全速推进”，那三弟你呢？
我的回答很简单——
我就是负责让身处新药研发江湖里的每一个你，都不再孤军奋战。
我是那个“连接一切”的人。
Click+Links：轻轻一点，新药闭环
“Click”——那是化学世界里最美妙的声音。两个原本毫不相干的分子模块，在催化剂的作用下，精准碰撞，瞬间生成一道牢不可破的共价键。没有犹豫，没有副反应，干净利落，一击即中。
“Links”——那是互联网世界最深邃的理想。超链接、超文本、万物互联。每一个节点都不是终点，而是通往更多可能性的入口。链链相扣，网网相通，终成一张覆盖全球的智慧网络。
两个词合在一起，就是我的使命：
用一击必中的精准，构建万物相连的生态；用化学键般的信任，缔造创新药江湖最牢固的合作网络。
我是谁？我是三优生物AI-STAL驱动的协同产业各方共同打造的创新药研发网络生态圈。我是那个把跨国药企的战略积淀、本土药企的锐意突破、高校院所的原始创新、CDMO/CRO的工艺匠心、投资机构的资本慧眼——统统“点击连接”在一起的那个催化剂。
在我的网络里，没有谁是一座孤岛。每一个合作伙伴，都能在一瞬间找到对的人、对的技术、对的资源。“咔嗒”一声，新的化学反应就开始了。
一个入口，六扇大门，近七十个专属平台
我通过一个一站式网页端入口，将药物研发的所有关键环节系统化整合，打造了六大核心模块，创新药研发最关键的能力模块，系统化整合在同一座“工场”里，每一个模块就好似一扇大门：
第一扇：核心试剂之门。
高质量的新药研发核心试剂，一键触达。不用再为了一个关键试剂苦等三个月，你的时间应该花在更值得的地方。
第二扇：新药发现之门。
从靶点验证到先导化合物优化，早期发现全流程一站式覆盖。让“从0到1”的荒原跋涉，变成有地图、有补给、有队友的科学远征。
第三扇：药理药效之门。
全面的临床前体内外药效学评价体系，让每一个候选分子都经得起科学的严苛审视。不靠运气，靠数据。
第四扇：创新技术之门。
前沿技术平台在此集结。mRNA编码抗体、AI分子生成、类器官评价体系……前沿探索者的武器库，随时向你开放。
第五扇：临床前研究之门。
一体化PCC-IND临床前评价能力，让“冲刺临床”不是惊险一跳，而是水到渠成的接力交接。
第六扇：疾病前沿之门。
聚焦人类肿瘤、代谢、自身免疫、神经、心血管、感染、眼科、衰老及宠物医疗九大核心战场。让研发方向始终锚定最迫切的临床需求，不跑偏，不盲从。
而撑起这六扇大门的，是近70个标准化、模块化的技术平台。
近70个平台，随时待命，灵活组合。单抗、双抗、多肽、核酸、ADC、APC、AOC、PDC、POC、CAR-T、TCR-T……只要你能说出名字的药物形态，我的工场就能为你配齐从设计到落地的全套装备。
开放共赢：多元模式，生态共建
Clicklinks，就是为回答这个问题而生的。
我们不让你一个人跑完全程。我们铺好跑道、架好桥梁、安排好每一个接力区的最强队友：
你有靶点构想？我有智能超万亿分子库AI-STAL为你备足武器。你需优化分子？我让有智能新药加速器SAI-DA全流程为你争分夺秒。你需产业伙伴？我用整个网络的生态力量为你精确制导。你需资本助力？共建研发平台、成立新公司、共同投资、合作开发……我把合作模式灵活安排，你想怎么合作，我们就怎么来。
开放共赢，生态共建是我刻在骨子里的基因。
从此，你的研发之路不再是一场孤独的马拉松。而是一场“里程碑式的接力跑”——每一棒都有最强队友接应，每一程都有专业力量护航，每一次交接，都让创新离患者更近一步。
新药研发梦，是大家共同的愿景。当越来越多带着Clicklinks烙印的原创新药，最终抵达全球患者身边，那才是这座创新工场真正的荣耀时刻。
原创新药创新工场Clicklinks的目标，是透彻解决创新药的源头创新问题，把新药研发的漫长马拉松变为里程碑接力跑，协同各方实现“让天下没有难做的创新药”的使命。
终有一天，Clicklinks将不只是三优生物旗下的一个平台，而是一个全球新药人共同实现新药梦想的舞台。
江湖路远，我等你来。
Clicklinks，轻轻一点，新药闭环。
Meet Clicklinks: The Innovation Hub for Original Drug Discovery
Introduction
Today, it is my turn — the youngest of the three brothers — to officially join this grand gathering of the pharmaceutical world.
My name is Clicklinks, known as the “Innovation Hub for Original Drug Discovery.” I am the youngest, and perhaps the most energetic, member under Sanyou Bio.
Some say my eldest brother is responsible for “the fountainhead of innovation,” while my second brother drives “full-speed execution.” So what about me?
My answer is simple:
I exist to ensure that no one in the world of novel drug discovery and development has to innovate in isolation.
I am the one who “connects everything.”
Click+Links: Click to Discover, Linked to Innovate
“Click” — the most beautiful sound in chemistry. Two molecular modules, originally unrelated, react with precision under catalytic action to form an unbreakable covalent bond. No hesitation. No side reactions. Clean, efficient, and perfectly targeted.
“Links” — the deepest ideal of the internet era. Hyperlinks, hypertext, universal connectivity. Every node is not an endpoint, but an entryway to greater possibilities. Link by link, network by network, forming a global web of intelligence.
Together, these two words embody my purpose: to build an interconnected ecosystem with precision and efficiency, and to create the most trusted collaborative network in innovative drug development — as strong and reliable as a chemical bond.
So who am I?
I am an AI-STAL-driven collaborative ecosystem that brings together all stakeholders across the innovative drug industry. I am the catalyst that “seamlessly connects” the strategic expertise of multinational pharmaceutical companies, the breakthrough spirit of local biotech innovators, the foundational discoveries of universities and research institutes, the craftsmanship of CDMOs and CROs, and the sharp vision of investment institutions.
Within my network, no one is an isolated island. Every partner can instantly find the right collaborators, technologies, and resources. With a single “click,” a new chemical reaction begins.
One Portal, Six Gateways, Nearly Seventy Dedicated Platforms
Through a one-stop web portal, I systematically integrate every critical stage of drug R&D into six core modules — six gateways within one unified “Innovation Hub.”
Gateway 1: Core Reagents
High-quality core reagents for innovative drug research, accessible with a single click. No more waiting three months for a critical reagent. Your time should be spent where it matters most.
Gateway 2: Drug Discovery
From target validation to lead optimization, the entire early discovery process is covered in one integrated solution. What was once a lonely “0-to-1” journey becomes a scientific expedition equipped with maps, supplies, and teammates.
Gateway 3: Pharmacology & Efficacy
A comprehensive preclinical in vitro and in vivo pharmacology evaluation system ensures every candidate molecule withstands rigorous scientific scrutiny. Not luck — data.
Gateway 4: Innovative Technologies
A gathering place for cutting-edge technology platforms: mRNA-encoded antibodies, AI-driven molecular generation, organoid evaluation systems, and more. The frontier explorer’s arsenal is always open to you.
Gateway 5: Preclinical Research
Integrated PCC-to-IND preclinical evaluation capabilities make the transition into clinical development not a risky leap, but a seamless relay handoff.
Gateway 6: Frontiers of Disease
Focused on nine major therapeutic battlegrounds: oncology, metabolism, autoimmune diseases, neuroscience, cardiovascular diseases, infectious diseases, ophthalmology, aging, and companion animal health. Keeping R&D aligned with the world’s most urgent clinical needs — without losing direction or following trends blindly.
Supporting these six gateways are nearly 70 standardized and modular technology platforms.
Nearly 70 platforms, always ready and flexibly combinable.
Monoclonal antibodies, bispecific antibodies, peptides, nucleic acids, ADCs, APCs, AOCs, PDCs, POCs, CAR-T, TCR-T — whatever therapeutic modality you can name, my Innovation Hub can equip you with everything from design to delivery.
Open Collaboration, Shared Success: Building the Ecosystem Together
Is the target validation robust enough?
Where will the lead molecule come from?
What is the optimal path for candidate optimization?
Who can undertake the preclinical work?
During difficult funding cycles, where will the next financing round come from?
And in the quiet of the night, perhaps you’ve asked yourself one more question:
Can I really walk this road alone?
Clicklinks was created to answer that question.
We do not expect you to run the entire race by yourself. We prepare the runway, build the bridges, and place the strongest teammates at every relay station.
Have a target concept? AI-STAL’s Super Trillion Antibody Library equips you with the tools you need.
Need molecular optimization? The Sanyou AI-Drug Accelerator streamlines the entire process, saving every possible moment.
Need strategic partners? I leverage the power of the entire ecosystem to connect you precisely with the right collaborators.
Need capital support? Co-built R&D platforms, new company formation, co-investment, collaborative development — we offer flexible partnership models tailored to your goals.
Open collaboration and ecosystem co-creation are embedded in my DNA.
From now on, your drug development journey no longer needs to feel like a lonely marathon. Instead, it becomes a milestone-driven relay race — where every stage is supported by the strongest teammates, every handoff is protected by professional expertise, and every transition brings innovation one step closer to patients.
The dream of innovative medicines belongs to all of us. And when more and more first-in-class therapies carrying the Clicklinks imprint ultimately reach patients around the world, that will be the proudest moment for this Innovation Hub.
The mission of Clicklinks is to fundamentally solve the challenge of source innovation in drug discovery — transforming the long marathon of drug development into a milestone relay race, and uniting all stakeholders to fulfill one shared vision:
“To make it easy to develop new drugs worldwide.”
One day, Clicklinks will no longer be just a platform under Sanyou Bio, but a global stage where innovators across the world come together to realize their pharmaceutical dreams.
The road ahead is long.
I’ll be waiting for you.
Clicklinks — Click to Discover, Linked to Innovate.
推荐阅读
SAI-DA 1.0 | 创新药你好，我叫智能新药加速器
AI-STAL 2.0 | 做药人你好，我是AI-STAL
Click & Go | 结直肠癌的差异化靶点
创新前沿 | OpenClaw化身生物医药智能工匠
Clicklinks | 三优AI-STAL 2.0-14天先导分子发现
浙江大学上海校友会莅临三优生物考察交流
Clicklinks | oneClick+ 人源化应用程序发布
三优大事记 | “荣膺上海市企业技术中心”
“为源头活水” | 企业家科学家共议原创新药研发生态
三优生物郎国竣：让天下没有难做的创新生物药
三优生物十周年庆典暨2026年年会
现场 | “2026中国新药源头创新论坛”
三优生物十年，从智能超万亿分子库到“创新工场”
不用部署模型，也能做蛋白结构预测？
盘点诺奖技术“噬菌体展示”孕育的抗体药物
三优十周年｜平台篇-抗体工程平台
关于三优生物
三优生物是一家以“让天下没有难做的创新药”为使命，致力于透彻解决创新药源头创新问题的生物医药高科技企业。
公司以智能超万亿分子库（AI-STAL）为核心驱动，以智能新药加速器（SAI-DA）为依托，致力于一站式透彻解决创新药各类分子产生和新药研发问题。
公司致力于打造全球顶尖的原创新药创新工场，协同各方共同加速全球创新药的研发进程。
公司总部位于中国上海，在亚洲、北美洲、欧洲等多地建立了业务中心，形成了全球化的业务网络，现有投产及布局的研发及GMP场地20000多平方米。
公司已与全球2000多家药企、生技公司等建立了良好的合作关系，已赋能1200多个新药研发项目；已完成50多个合作研发项目，其中10多个协同研发项目已推至IND及临床研发阶段。
公司已申请170多项发明专利，其中30多项发明专利已获得授权，并获得了国家级高新技术企业、上海市专精特新、ISO9001、ISO27001等10余项资质及体系认证。
推荐阅读
SAI-DA 1.0 | 创新药你好，我叫智能新药加速器
AI-STAL 2.0 | 做药人你好，我是AI-STAL
AI-STAL 2.0 | 做药人你好，我是AI-STAL
Click & Go | 结直肠癌的差异化靶点
创新前沿 | OpenClaw化身生物医药智能工匠
Clicklinks | 三优AI-STAL 2.0-14天先导分子发现
浙江大学上海校友会莅临三优生物考察交流
Clicklinks | oneClick+ 人源化应用程序发布
三优大事记 | “荣膺上海市企业技术中心”
“为源头活水” | 企业家科学家共议原创新药研发生态
三优生物郎国竣：让天下没有难做的创新生物药
三优生物十周年庆典暨2026年年会
现场 | “2026中国新药源头创新论坛”
三优生物十年，从智能超万亿分子库到“创新工场”
不用部署模型，也能做蛋白结构预测？
盘点诺奖技术“噬菌体展示”孕育的抗体药物
三优十周年｜平台篇-抗体工程平台
关于三优生物
三优生物是一家以“让天下没有难做的创新药”为使命，致力于透彻解决创新药源头创新问题的生物医药高科技企业。
公司以智能超万亿分子库（AI-STAL）为核心驱动，以智能新药加速器（SAI-DA）为依托，致力于一站式透彻解决创新药各类分子产生和新药研发问题。
公司致力于打造全球顶尖的原创新药创新工场，协同各方共同加速全球创新药的研发进程。
公司总部位于中国上海，在亚洲、北美洲、欧洲等多地建立了业务中心，形成了全球化的业务网络，现有投产及布局的研发及GMP场地20000多平方米。
公司已与全球2000多家药企、生技公司等建立了良好的合作关系，已赋能1200多个新药研发项目；已完成50多个合作研发项目，其中10多个协同研发项目已推至IND及临床研发阶段。
公司已申请170多项发明专利，其中30多项发明专利已获得授权，并获得了国家级高新技术企业、上海市专精特新、ISO9001、ISO27001等10余项资质及体系认证。
